| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.0006 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.001 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |